SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lance Jean Fitterer

(Last)

(First)

(Middle)

ONE BOSTON SCIENTIFIC PLACE

(Street)

NATICK

01760-1537

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/10/2010

3. Issuer Name and Ticker or Trading Symbol
BOSTON SCIENTIFIC CORP [ BSX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP & Chief Compliance Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	48,117⁽¹⁾	D
Common Stock	3,922	I	By 401(k)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Deferred Stock Units	⁽²⁾	⁽²⁾	Common Stock	33,119⁽³⁾	⁽²⁾	D
Stock Option (Right to Buy)	⁽⁴⁾	12/06/2010	Common Stock	26,668	$6.125	D
Stock Option (Right to Buy)	⁽⁵⁾	02/24/2019	Common Stock	33,512	$8.3	D
Stock Option (Right to Buy)	⁽⁶⁾	07/25/2010	Common Stock	30,000	$8.5	D
Stock Option (Right to Buy)	⁽⁷⁾	12/17/2011	Common Stock	15,000	$12.5	D
Stock Option (Right to Buy)	⁽⁸⁾	05/09/2010	Common Stock	24,200	$14.1563	D
Stock Option (Right to Buy)	⁽⁹⁾	12/09/2012	Common Stock	16,000	$21.255	D

Explanation of Responses:

1. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan.

2. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

3. Reflects multiple DSU awards with independent vesting schedules.

4. Grant to the reporting person on December 6, 2000, of an option to purchase 80,000 shares of common stock. This grant is fully vested.

5. Grant to the reporting person of an option to purchase 33,512 shares of common stock vesting in four equal annual increments beginning on February 24, 2010, the first anniversary of the grant.

6. Grant to the reporting person on July 25, 2000, of an option to purchase 30,000 shares of common stock. This grant is fully vested.

7. Grant to the reporting person on December 17, 2001, of an option to purchase 15,000 shares of common stock. This grant is fully vested.

8. Grant to the reporting person on May 9, 2000, of an option to purchase 24,200 shares of common stock. This grant is fully vested.

9. Grant to the reporting person on December 9, 2002, of an option to purchase 16,000 shares of common stock. This grant is fully vested.

Remarks:

lancepoa.TXT

	/s/ Lawrence J. Knopf, Attorney-in-fact	02/17/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.